What one share of Synergy CHC holds
Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain
Synergy CHC’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $2.67 |
|---|---|
| Profit | −$1.52 |
| Cash and investments | $0.03 |
| Debt | $2.45 |
| Book value | −$2.25 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $5.80 | $0.86 | — | — | — | −$3.70 |
| 2024 | $4.57 | $0.28 | — | — | — | −$1.95 |
| 2025 | $3.12 | −$1.27 | — | — | — | −$2.05 |
Common questions about Synergy CHC
How much does one share of Synergy CHC earn?
Over the last 12 months, Synergy CHC lost $1.52 for each share on $2.67 of sales.
Does Synergy CHC pay a dividend?
Synergy CHC didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Synergy CHC’s book value per share?
Synergy CHC’s book value is negative (−$2.25 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of March 31, 2026.
How much cash and debt does each share of Synergy CHC have?
Each share of Synergy CHC has $0.03 of cash and investments and $2.45 of debt, as of March 31, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.